Syngene International




MarketCap IN

IN India


Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it offers other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter Inc.; and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.


Syngene was founded in 1993 and is headquartered in Bengaluru. The company was begun with an investment of INR 8.5 crores by Biocon. Today, Syngene operates out of its headquarters in Bengaluru, India as well as offices in San Francisco and Shanghai, China.

To enable our customers succeed through innovative and integrated scientific solutions, with extraordinary engagement experiences and a commitment to operational excellence.

To be a world class partner delivering innovative scientific solutions.

Key Team

Krishnan G (Head of Investor Relations)

Ms. Priyadarshini Mahapatra C.S. (Company Sec. & Compliance Officer)

Mr. Sandeep Nair (Head of Corp. Communications)

Mr. Sanjeev Sukumaran (Chief HR Officer)

Dr. Dhananjay Patankar (Head of Pharmaceutical & Biopharmaceutical Devel.)

Mr. Purushottam Shashikant Singnurkar (Head of Formulations Devel.)

Mr. Ajit Manocha (Head of IT)

Recognition and Awards
Syngene's innovation and commitment to quality has resulted in their numerous acclaims and awards such as the Bengaluru Bio Excellence Awards, Frost & Sullivan Manufacturing Leadership Award, ICICI Bank's International Business Awards and more.

Syngene International
Leadership team

Mr. Jonathan Brittan Hunt (MD, CEO & Exec. Director)

Mr. Sibaji Biswas (Chief Financial Officer)

Dr. Mahesh Bhalgat Ph.D. (Chief Operating Officer)

Products/ Services
Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Bangalore, Karnataka, India
Net Income
20M - 100M
100M - 500M
Traded as
Social Media
Fri Mar 01 2024

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with

Copyright 2023 © businessabc powered by ztudium